Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Teva $1 Billion Market Depends on New Test of Laquinimod
Aug. 28, 2012
Teva Pharmaceutical is recruiting about 1,800 patients for a new trial of its multiple sclerosis pill in a bid to improve how the disease is treated and secure a successor to its best-selling medicine.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing